electroCore (NASDAQ:ECOR) Insider Michael Fox Purchases 2,500 Shares of Stock

electroCore, Inc. (NASDAQ:ECOR – Get Free Report) insider Michael Fox bought 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 17th. The shares were acquired at an average price of $5.25 per share, with a total value of $13,125.00. Following the purchase, the insider owned 132,500 shares of the company’s stock, valued at $695,625. The trade was a 1.92% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

electroCore Stock Down 5.1%

Shares of ECOR opened at $4.91 on Friday. The company has a market capitalization of $45.27 million, a price-to-earnings ratio of -3.53 and a beta of 1.23. electroCore, Inc. has a 52-week low of $4.37 and a 52-week high of $12.70. The stock has a 50 day moving average price of $8.67 and a 200 day moving average price of $7.70.

electroCore (NASDAQ:ECOR – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.14. The company had revenue of $9.69 million for the quarter, compared to analyst estimates of $10.93 million. On average, equities analysts anticipate that electroCore, Inc. will post -1.17 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in electroCore stock. Cetera Investment Advisers bought a new stake in electroCore, Inc. (NASDAQ:ECOR – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 32,950 shares of the company’s stock, valued at approximately $357,000. Cetera Investment Advisers owned about 0.36% of electroCore as of its most recent filing with the Securities & Exchange Commission. 26.74% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research report on Monday, September 21st. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $18.00.

Get Our Latest Research Report on electroCore

About electroCore

(Get Free Report)

electroCore is a medical technology company that develops non-invasive bioelectronic therapies. Its products use non-invasive vagus nerve stimulation (nVNS), which delivers gentle electrical stimulation through the skin to activate the vagus nerve. The company’s gammaCore device is used for the treatment of certain headache conditions, including migraine and cluster headache, subject to its regulatory clearances and indications. electroCore also offers Truvaga, a consumer wellness product that uses non-invasive vagus nerve stimulation.

See Also

Insider Buying and Selling by Quarter for electroCore (NASDAQ:ECOR)

Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.